Ventyx Biosciences (VTYX) Earnings Date & Reports

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

VTYX is expected to report earnings to rise 22.72% to -47 cents per share on August 07

Ventyx Biosciences VTYX Stock Earnings Reports

Q2'25

Est.

$-0.48

Q1'25

Beat

by $0.10

Q4'24

Beat

by $0.13

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.13

The last earnings report on May 08 showed earnings per share of -38 cents, beating the estimate of -49 cents. With 1.91M shares outstanding, the current market capitalization sits at 99.63M.

View a ticker or compare two or three

Compare

VTYX